Discovery of low‐molecular‐weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stability
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29594 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Xiangyi Jiang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of …. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Seropositivity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC No. 82173677), Key Research and Development Program, Ministry of Science and Technology of the People's Repu…, National Natural Science Foundation of China, Key Research and Development Program, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
The HIV capsid (CA) protein is a promising target for anti‐AIDS treatment due to its critical involvement in viral replication. Herein, we utilized the well‐documented CA inhibitor PF74 as our lead compound and designed a series of low‐molecular‐weight phenylalanine derivatives. Among them, compound 7t exhibited remarkable antiviral activity with a high selection index (EC 50 = 0.040 µM, SI = 2815), surpassing that of PF74 (EC 50 = 0.50 µM, SI = 258). Furthermore, when evaluated against the HIV‐2 strain, 7t (EC 50 = 0.13 µM) demonstrated approximately 14‐fold higher potency than that of PF74 (EC 50 = 1.76 µM). Insights obtained from surface plasmon resonance (SPR) revealed that 7t exhibited stronger target affinity to the CA hexamer and monomer in comparison to PF74 . The potential interactions between 7t and the HIV‐1 CA were further elucidated using molecular docking and molecular dynamics simulations, providing a plausible explanation for the enhanced target affinity with 7t over PF74 . Moreover, the metabolic stability assay demonstrated that 7t ( T 1/2 = 77.0 min) significantly outperforms PF74 ( T 1/2 = 0.7 min) in human liver microsome, exhibiting an improvement factor of 110‐fold. In conclusion, 7t emerges as a promising drug candidate warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of C…
- HeteroChem InnoTech, Hansraj College Campus (University of Delhi), Delhi, India.
- H.G. Khorana Centre For Chemical Biology, Department of Chemistry, Hansraj College, University of Delhi, Delhi, India.
- Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Leuven, Belgium.
- Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
- China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province, Jinan, Shandong, People's Republic of China.
ORCID-Profile: Xiangyi Jiang
Förderung
- National Natural Science Foundation of China (NSFC No. 82173677), Key Research and Development Program, Ministry of Science and Technology of the People's Repu…
- National Natural Science Foundation of China
- Key Research and Development Program, Ministry of Science and Technology of the People's Republic of China
- Science Foundation for Outstanding Young Scholars of Shandong Province
- Shandong Laboratory Program
- National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)
Zitieren
APA
Jiang, X., Gao, Z., Sharma, P. P., Kumar, S., Rathi, B., Ji, X., Dai, J., Xie, M., Dong, G., Xu, S., De Clercq, E., Pannecouque, C., Dick, A., Zhan, P., & Liu, X. (2024). Discovery of low‐molecular‐weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stability. Journal of Medical Virology. https://doi.org/10.1002/jmv.29594
Vancouver
Jiang X, Gao Z, Sharma PP, Kumar S, Rathi B, Ji X, et al. Discovery of low‐molecular‐weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stability. Journal of Medical Virology. 2024. doi:10.1002/jmv.29594
BibTeX
@article{Jiang2024,
author = {Jiang, Xiangyi and Gao, Zhen and Sharma, Prem Prakash and Kumar, Sumit and Rathi, Brijesh and Ji, Xiangkai and Dai, Jiaojiao and Xie, Minghui and Dong, Guanyu and Xu, Shujing and De Clercq, Erik and Pannecouque, Christophe and Dick, Alexej and Zhan, Peng and Liu, Xinyong},
title = {Discovery of low‐molecular‐weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stability},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29594}
}
EUVIMED